| Lonza Group AG | 328.00 |
| Date/Time | 06/28 / 17:19 |
| Chg. / Chg.(%) | - / |
| Bid | 316.00 / 1000 |
| Ask | 339.00 / 1000 |
| Open | 323.10 |
| Previous Close | 324.40 |
| High | 328.50 |
| Low | 322.50 |
| Volume [CHF] | 4,214,337.55 |
| Volume [Units] | 12,923 |
| Price fixings | 611 |
| ISIN | CH0013841017 |
| Security | LONN/Z |
| Exchange | Cboe Europe BXE |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| SIX Swiss Ex.. | 336.80 |  |
282,984 |
| London Inter.. | 337.01 | |
15,457 |
| Nasdaq Other.. | 341.5081 | |
15 |
| Lang & Schwa.. | 305.100 | |
|
| Cboe Europe .. | 328.30 | 47,868 | |
| Turquoise | 328.30 |  |
18,782 |
| Cboe Europe .. | 328.00 | 12,923 | |
| TradeGate | 294.000 | 298 | |
| Stuttgart | 294.000 | 135 | |
| Frankfurt | 293.9000 | 63 | |
| Düsseldorf | 291.20 | 0 | |
| München | 291.30 | 0 | |
| Berlin | 296.90 | 0 | |
| Hamburg | 291.30 | 0 | |
| gettex | 296.100 | ||
| Singapore | 79.97 | 500 | |
| EUREX | Options | ||
News
- Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson’s Disease
12/04/2019 / 13:36 - GlobeNewswire - Amarantus Announces Issuance of Chinese Patent Covering the Use of MANF and CDNF in Retinal Disorders for Subsidiary MANF Therapeutics
11/21/2019 / 14:00 - GlobeNewswire - Amarantus Provides Recapitalization Update to Shareholders
11/18/2019 / 14:30 - GlobeNewswire - Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test Relationship with Amyloid PET
11/14/2019 / 17:02 - GlobeNewswire - Global Primary Cells Market Analysis, Trends, and Forecasts Report 2019
10/30/2019 / 11:17 - GlobeNewswire
Real-time